JP2024504390A5 - - Google Patents

Info

Publication number
JP2024504390A5
JP2024504390A5 JP2023544446A JP2023544446A JP2024504390A5 JP 2024504390 A5 JP2024504390 A5 JP 2024504390A5 JP 2023544446 A JP2023544446 A JP 2023544446A JP 2023544446 A JP2023544446 A JP 2023544446A JP 2024504390 A5 JP2024504390 A5 JP 2024504390A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence described
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023544446A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/070326 external-priority patent/WO2022159984A1/en
Publication of JP2024504390A publication Critical patent/JP2024504390A/ja
Publication of JP2024504390A5 publication Critical patent/JP2024504390A5/ja
Pending legal-status Critical Current

Links

JP2023544446A 2021-01-22 2022-01-24 抗her-2/trop-2構築物及びその使用 Pending JP2024504390A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163140638P 2021-01-22 2021-01-22
US63/140,638 2021-01-22
PCT/US2022/070326 WO2022159984A1 (en) 2021-01-22 2022-01-24 Anti-her-2/trop-2 constructs and uses thereof

Publications (2)

Publication Number Publication Date
JP2024504390A JP2024504390A (ja) 2024-01-31
JP2024504390A5 true JP2024504390A5 (cg-RX-API-DMAC7.html) 2025-02-03

Family

ID=80595406

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023544446A Pending JP2024504390A (ja) 2021-01-22 2022-01-24 抗her-2/trop-2構築物及びその使用

Country Status (6)

Country Link
US (1) US20240101717A1 (cg-RX-API-DMAC7.html)
EP (1) EP4281484B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024504390A (cg-RX-API-DMAC7.html)
KR (1) KR20230147092A (cg-RX-API-DMAC7.html)
CN (1) CN116917326A (cg-RX-API-DMAC7.html)
WO (1) WO2022159984A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023210951A1 (en) * 2022-01-26 2024-07-04 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Anti-her2/trop2 antibodies and uses thereof
WO2024012566A2 (en) * 2022-07-15 2024-01-18 Genequantum Healthcare (Suzhou) Co., Ltd. Antibody, linkers, payload, conjugates and applications thereof
WO2024046455A1 (en) * 2022-09-01 2024-03-07 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Methods for preparing antibody-drug conjugates
EP4688865A2 (en) * 2023-03-29 2026-02-11 Mythic Therapeutics, Inc. Trop2-binding proteins and uses thereof
CN122270469A (zh) * 2023-09-28 2026-06-23 默沙东有限责任公司 免疫偶联物用于治疗非小细胞肺癌的用途
WO2025111445A1 (en) * 2023-11-21 2025-05-30 Convergent Therapeutics, Inc. Trop-2 radiopharmaceutical conjugate and uses thereof
WO2025191139A1 (en) * 2024-03-15 2025-09-18 Avidicure Ip B.V. Conjugates of her2-specific antigen binding proteins and cytokines
KR20250175725A (ko) * 2024-06-07 2025-12-17 (주)지아이이노베이션 Cd80 단백질 및 il-2 단백질을 포함하는 융합단백질 및 항체-약물 접합체를 포함하는 암 치료용 약학 조성물

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3817827A (en) 1972-03-30 1974-06-18 Scott Paper Co Soft absorbent fibrous webs containing elastomeric bonding material and formed by creping and embossing
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
DE3307869A1 (de) 1983-03-05 1984-09-06 Dragoco Gerberding & Co Gmbh, 3450 Holzminden Methylsubstituierte 1-((3-methylthio)-1-oxo-butyl)-cyclohex-2-ene, verfahren zu deren herstellung und deren verwendung als riech- und aromastoffe
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0335476A3 (en) 1984-02-08 1989-12-13 Cetus Corporation Recombinant methods for the production of ricin a, ricin b, ricin or diphtheria toxin (dt)a or ab' fragment, suitable hosts and vectors therefor, and conjugates comprising ricin toxin a chain or diphtheria toxin
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
FI903489A7 (fi) 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
US6027725A (en) 1991-11-25 2000-02-22 Enzon, Inc. Multivalent antigen-binding proteins
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
US5698413A (en) 1993-05-05 1997-12-16 The United States Of America As Represented By The Department Of Health And Human Services Method of evaluating chemotherapeutic agents in vivo
US6074642A (en) 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
CA2326389C (en) 1998-04-21 2007-01-23 Micromet Gesellschaft Fur Biomedizinische Forschung Mbh Novel cd19xcd3 specific polypeptides and uses thereof
US20030083263A1 (en) 2001-04-30 2003-05-01 Svetlana Doronina Pentapeptide compounds and uses related thereto
US6884869B2 (en) 2001-04-30 2005-04-26 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
CA2478047C (en) * 2002-03-01 2014-01-21 Immunomedics, Inc. Rs7 antibodies
JP2005522514A (ja) * 2002-04-10 2005-07-28 ジェネンテック・インコーポレーテッド 抗her2抗体改変体
US7393531B2 (en) * 2003-01-21 2008-07-01 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
ES2605443T3 (es) 2003-11-06 2017-03-14 Seattle Genetics, Inc. Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
US20080305044A1 (en) 2004-11-29 2008-12-11 Seattle Genetics, Inc. Engineered Antibodies and Immunoconjugates
ES2978993T3 (es) * 2014-02-21 2024-09-23 Ibc Pharmaceuticals Inc Terapia de enfermedades mediante la inducción de la respuesta inmunitaria a las células que expresan Trop-2
CA3036564A1 (en) * 2016-09-23 2018-03-29 Elstar Therapeutics, Inc. Multispecific antibody molecules comprising lambda and kappa light chains
SG10201913263SA (en) * 2016-09-29 2020-03-30 Beijing Hanmi Pharmaceutical Co Ltd Heterodimeric immunoglobulin constructs and preparation methods thereof
WO2018176159A1 (en) * 2017-03-31 2018-10-04 Zymeworks Inc. Tumor antigen presentation inducer constructs and uses thereof
WO2019222428A1 (en) * 2018-05-16 2019-11-21 Arbele Limited Composition of bispecific antibodies and method of use thereof
EP3906055A4 (en) * 2019-01-04 2023-01-04 Trio Pharmaceuticals, Inc. MULTISPECIFIC PROTEIN MOLECULES AND THEIR USES
CN116745316A (zh) * 2020-09-04 2023-09-12 武田药品工业有限公司 具有人血清白蛋白结构域的受限条件激活结合蛋白构建体

Similar Documents

Publication Publication Date Title
US12595312B2 (en) CD133-binding agents and uses thereof
CN102741282B (zh) 针对转铁蛋白受体的抗体以及其用于依赖于铁的肿瘤的免疫疗法的用途
JP7806138B2 (ja) a-syn/IGF1Rに対する二重特異抗体およびその用途
JP2023543031A5 (cg-RX-API-DMAC7.html)
US20090028859A1 (en) Bispecific antibodies that bind to vegf receptors
JP7827624B2 (ja) 抗cea抗体-エキサテカン類似体複合体及びその医薬用途
JP2023516004A5 (cg-RX-API-DMAC7.html)
BRPI0707824A2 (pt) proteÍna de ligaÇço a antÍgeno, e, mÉtodos de neutralizaÇço da ativaÇço de um receptor de tirosina quinase, de inibiÇço de angiogÊnese, de reduÇço de crescimento de tumor e de produÇço de uma proteÍna de ligaÇço a antÍgeno
JP2018108081A (ja) Vegfを阻害する安定かつ可溶性の抗体
US12624123B2 (en) Compositions and methods for reducing off-target toxicity of antibody drug conjugates
JP2023529842A5 (cg-RX-API-DMAC7.html)
JP2021523100A5 (cg-RX-API-DMAC7.html)
JP2023536461A5 (cg-RX-API-DMAC7.html)
KR20230132544A (ko) 신규한 항-그렘린1 항체
JP2023516941A5 (cg-RX-API-DMAC7.html)
JP2025513745A5 (cg-RX-API-DMAC7.html)
JP7197078B2 (ja) プレクチン1結合性抗体およびその使用
CA3225975A1 (en) Drug conjugate of eribulin derivative
CN110090306B (zh) 双醛连接臂的配体-药物偶联物、其制备方法及其应用
JP2025524306A (ja) Itga2を標的とする抗体及びそれを含む抗体薬物複合体
AU2022293634A1 (en) Anti-her3 antibody, antibody drug conjugate containing the same, and use thereof
WO2004003211A1 (en) Bispecific antibodies that bind to vegf receptors
JP2026512687A (ja) ヒト化l1cam抗体-薬物複合体
TW202432185A (zh) 配體-細胞毒性藥物綴合物及其藥物用途
CN113329769A (zh) 具有反应性精氨酸的抗体化合物及相关的抗体药物缀合物